Skip to main content
logo
Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
3.880
+0.090 (2.37%)
At close: Jun 18, 2026, 4:00 PM EDT
3.940
+0.060 (1.55%)
After-hours: Jun 18, 2026, 7:57 PM EDT

Oramed Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1591129793476545
Market Cap Growth
72.04%15.87%3.67%-80.42%-12.65%-21.55%
Enterprise Value
75.75-17.77-45.87-18.17320.47399.29
Last Close Price
3.882.852.422.3112.0314.28
PE Ratio
1.511.90-16.50-46.70
PS Ratio
-55.97-69.54176.08602.77
PB Ratio
0.670.560.660.573.143.27
P/TBV Ratio
0.680.610.680.573.093.27
EV/Sales Ratio
--8.89--13.56118.56441.69
EV/EBITDA Ratio
-1.193.641.17-32.35
EV/EBIT Ratio
-1.183.591.15-32.39
EV/FCF Ratio
-1.945.441.72--
Debt / Equity Ratio
0.000.000.000.320.000.00
Debt / EBITDA Ratio
-----0.04
Net Debt / Equity Ratio
-0.27-0.65-0.97-0.67-1.02-0.88
Net Debt / EBITDA Ratio
4.618.6711.257.093.82-11.81
Net Debt / FCF Ratio
7.6114.1716.7910.475.4513.10
Asset Turnover
-0.0100.010.020.01
Quick Ratio
6.236.8424.973.0527.1019.85
Current Ratio
6.456.9825.193.0627.3420.08
Return on Equity (ROE)
50.21%37.10%-12.39%3.24%-23.77%12.29%
Return on Assets (ROA)
-4.76%-6.64%-8.16%-8.25%-23.98%11.08%
Return on Invested Capital (ROIC)
-7.60%-21.00%-25.24%-27.34%-209.63%62.28%
Return on Capital Employed (ROCE)
-6.06%-8.35%-8.07%-9.76%-24.88%11.71%
Earnings Yield
68.76%52.63%-6.06%-2.14%
Dividend Yield
6.44%0.00%0.00%0.00%0.00%0.00%
Payout Ratio
9.72%0.00%0.00%0.00%0.00%0.00%
Buyback Yield / Dilution
-4.04%-3.84%-0.70%-4.02%-2.20%-34.04%
Total Shareholder Return
2.40%-3.84%-0.70%-4.02%-2.20%-34.04%
SEC Filings: 10-K · 10-Q